USE OF THE NEW ANTIEPILEPTIC DRUG PERAMPANEL (FYCOMPA) IN THE TREATMENT OF EPILEPSY: A REVIEW OF FOREIGN LITERATURE
Despite a considerable advance made in epileptology, resistant epilepsies are about 30% among all epilepsy types particularly in patients with focal seizures. In these cases, there is hope for the success of neurosurgical treatment and the synthesis of new antiepileptic drugs (AEDs). The authors pro...
Main Authors: | O. A. Pylaeva, K. Yu. Mukhin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-04-01
|
Series: | Russkij Žurnal Detskoj Nevrologii |
Subjects: | |
Online Access: | https://rjdn.abvpress.ru/jour/article/view/29 |
Similar Items
-
PERAMPANEL (FYCOMPA) FOR TREATMENT OF EPILEPSY (EXPERIENCE OF THE SVT. LUKA'S INSTITUTE OF CHILD NEUROLOGY AND EPILEPSY)
by: K. Yu. Mukhin, et al.
Published: (2015-04-01) -
Current role of perampanel in pediatric epilepsy
by: Paola De Liso, et al.
Published: (2017-06-01) -
Perampanel in the treatment of drug-resistant epilepsy in children
by: M. Yu. Bobylova, et al.
Published: (2018-01-01) -
IMPACT OF ANTIEPILEPTIC DRUGS ON COGNITIVE FUNCTIONS: FOCUS ON PERAMPANEL
by: E. D. Belousova
Published: (2016-12-01) -
Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy
by: Faulkner MA
Published: (2017-10-01)